Vanguard Group’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,086,207
Closed -$172M 4174
2018
Q4
$172M Buy
3,086,207
+124,071
+4% +$6.74M 0.01% 1335
2018
Q3
$138M Buy
2,962,136
+88,987
+3% +$4.31M 0.01% 1629
2018
Q2
$139M Buy
2,873,149
+136,980
+5% +$6.55M 0.01% 1598
2018
Q1
$118M Buy
2,736,169
+89,286
+3% +$4.01M 0.01% 1626
2017
Q4
$105M Buy
2,646,883
+167,283
+7% +$6.97M ﹤0.01% 1684
2017
Q3
$108M Buy
2,479,600
+40,360
+2% +$1.84M 0.01% 1659
2017
Q2
$117M Buy
2,439,240
+99,799
+4% +$4.65M 0.01% 1587
2017
Q1
$96M Buy
2,339,441
+102,779
+5% +$4.29M ﹤0.01% 1667
2016
Q4
$85.9M Buy
2,236,662
+71,642
+3% +$2.91M ﹤0.01% 1721
2016
Q3
$116M Buy
2,165,020
+87,755
+4% +$4.07M 0.01% 1467
2016
Q2
$89.3M Buy
2,077,265
+165,851
+9% +$6.96M 0.01% 1590
2016
Q1
$96.5M Buy
1,911,414
+52,837
+3% +$2.54M 0.01% 1508
2015
Q4
$118M Buy
1,858,577
+51,848
+3% +$3.53M 0.01% 1351
2015
Q3
$118M Buy
1,806,729
+110,632
+7% +$7.34M 0.01% 1318
2015
Q2
$115M Buy
1,696,097
+79,093
+5% +$4.36M 0.01% 1427
2015
Q1
$69M Buy
1,617,004
+235,045
+17% +$10.5M ﹤0.01% 1750
2014
Q4
$68.3M Buy
1,381,959
+94,801
+7% +$3.8M ﹤0.01% 1675
2014
Q3
$37M Buy
1,287,158
+6,705
+0.5% +$182K ﹤0.01% 1953
2014
Q2
$33.5M Sell
1,280,453
-23,679
-2% -$611K ﹤0.01% 2020
2014
Q1
$72.6M Buy
1,304,132
+167,335
+15% +$9.63M 0.01% 1581
2013
Q4
$54.7M Buy
1,136,797
+135,773
+14% +$5.71M ﹤0.01% 1728
2013
Q3
$42.1M Buy
1,001,024
+127,839
+15% +$6.09M ﹤0.01% 1819
2013
Q2
$39.3M Buy
+873,185
New +$34.2M ﹤0.01% 1777

Vanguard Group's IMPV Position: Q1 2019 in Review

Vanguard Group sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 3,086,207 shares — an estimated $172M sold.

Vanguard Group first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $172M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Vanguard Group reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Vanguard Group sold 3,086,207 Imperva, Inc. shares in Q1 2019, an estimated $172M.
  • Vanguard Group first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
  • Vanguard Group's Imperva, Inc. position peaked at $172M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Vanguard Group's 13F filing for Q1 2019, filed 15 May 2019.